Cabergoline Tablets (Generic Dostinex)
Cabergoline—widely known under the reference clinical trade name Dostinex—is a potent synthetic ergoline derivative and long-acting dopamine receptor agonist. Specifically engineered to target dopamine D2 receptors within the anterior pituitary gland, cabergoline is the premier pharmacological tool for the management of hyperprolactinemia, treatment of prolactinomas, and suppression of prolactin-mediated side effects induced by 19-nortestosterone compounds during advanced athletic and bodybuilding protocols.
Our verified catalog offers authentic pharmaceutical-grade cabergoline tablets manufactured under strict laboratory standards, ensuring precise micro-dose active substance uniformity, rapid bioavailability, and certified chemical purity.
Mechanism of Action & Dopaminergic Activity
The primary pharmacodynamics of cabergoline center around its high selective affinity for dopamine D2 receptors located on pituitary lactotroph cells:
- Targeted Pituitary Prolactin Inhibition: Direct stimulation of dopamine D2 receptors mimics the natural inhibitory feedback of endogenous dopamine, significantly decreasing both the baseline synthesis and pulsatile systemic release of prolactin.
- Extended Pharmacokinetic Half-Life: Displays exceptional metabolic stability and prolonged receptor binding, yielding an active terminal elimination half-life of roughly 63 to 69 hours, allowing steady prolactin suppression with infrequent micro-dosing.
- Neurological Drive & Refractory Period Reduction: By optimizing the dopamine-to-prolactin balance, it supports central nervous system drive, counters sexual dysfunction, and significantly reduces the male post-ejaculatory refractory period.
Technical Specifications & Administration Protocols
Cabergoline is pressed into scored oral tablets to allow accurate micro-titration. Because of its prolonged biological activity, administration protocols are scheduled on an intermittent basis (typically twice weekly or once every 3 to 4 days) rather than daily.
| Specification | On-Cycle Prolactin Management (19-nor) | Acute Hyperprolactinemia Intervention |
|---|---|---|
| Formulation Type | Oral scored tablets | Oral scored tablets |
| Administration Frequency | Twice weekly (e.g., Monday / Thursday) | Twice weekly (adjusted per bloodwork) |
| Protocol Duration | Concurrently with progestogenic compounds | 4–8 weeks (until prolactin normalizes) |
| Primary Focus | Prolactin suppression & sexual function | Lactotroph regulation & biomarker balance |
| Active Half-Life | Approx. 63–69 hours | Approx. 63–69 hours |
Primary Applications in Performance Regimens
- 19-Nor Ancillary Support: Crucial ancillary agent when running compounds with progestogenic activity such as Nandrolone (Deca / NPP) or Trenbolone, preventing prolactin spikes that can lead to prolactin-induced gynecomastia and sexual dysfunction.
- Prevention of Prolactin-Mediated Gynecomastia: Neutralizes glandular sensitivity in the breast tissue when elevated prolactin interacts synergistically with circulating estrogens.
- Dopaminergic Tone & Well-Being: Promotes enhanced mood, focus, and libido by elevating dopaminergic signaling while suppressing excess systemic prolactin concentrations.
Biomarker Health & Protocol Guidelines
Because of cabergoline’s potency as a dopaminergic agonist, administration should be disciplined and guided by routine biological assessment:
- Bloodwork-Guided Titration: Dosing should always be titrated based on serum prolactin blood tests. Excessively driving prolactin below reference ranges is unnecessary and can negatively affect immune and neurological function.
- Blood Pressure Monitoring: As a dopamine agonist, cabergoline can exert mild peripheral vasodilatory effects that may transiently lower orthostatic blood pressure. Taking tablets with an evening meal minimizes mild dizziness or nausea.
- Conservative Dosing Strategy: Due to its long half-life and high receptor affinity, excessive dosing must be avoided. Conservative, spaced administration yields stable and targeted therapeutic outcomes.
Quality Certification & Order Fulfillment
- HPLC Lab Certified: All tablet batches undergo independent high-performance liquid chromatography testing to confirm exact active substance micro-titration, formulation stability, and zero contaminants.
- Discreet & Neutral Packaging: Blister packs and bottles are dispatched in unmarked, shock-resistant protective mailers with no external indicators to maintain total recipient privacy.
- Tracked Global Transit: Reliable dispatch paired with real-time end-to-end tracking provides continuous transparency from fulfillment directly to your destination.